Security
SEER · Seer, Inc.
SEERNASDAQCommon stockCurrentCIK 1726445Updated Sep 24, 2026
Name history
Seer Biosciences, Inc. · through Jan 4, 2018
SEER price & chart
Loading TradingView…
NASDAQ:SEER on TradingView ↗About the company
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.
In the news
Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Other Events
Items 8.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 296,083,000Source | 366,597,000Source | 436,269,000Source | 487,929,000Source |
| Property, Plant and Equipment, NetUSD | 14,754,000Source | 18,575,000Source | 22,193,000Source | 19,408,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 47,285,000Source | 40,753,000Source | 32,499,000Source | 53,208,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | 4,315,000Source |
| Inventory, NetUSD | 7,795,000Source | 7,436,000Source | 4,491,000Source | 4,627,000Source |
| Assets, CurrentUSD | 201,534,000Source | 253,323,000Source | 330,513,000Source | 434,982,000Source |
| Operating Lease, Right-of-Use AssetUSD | 20,488,000Source | 22,791,000Source | 25,177,000Source | 27,003,000Source |
| Other Assets, NoncurrentUSD | 4,097,000Source | 8,281,000Source | 1,004,000Source | 855,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 36,776,000Source | 39,028,000Source | 39,365,000Source | 40,936,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 724,819,000Source | 719,804,000Source | 702,868,000Source | 667,739,000Source |
| Retained Earnings (Accumulated Deficit)USD | -465,972,000Source | -392,372,000Source | -305,773,000Source | -219,496,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 459,000Source | 136,000Source | -192,000Source | -1,251,000Source |
| Stockholders' Equity Attributable to ParentUSD | 259,307,000Source | 327,569,000Source | 396,904,000Source | 446,993,000Source |
| Liabilities and EquityUSD | 296,083,000Source | 366,597,000Source | 436,269,000Source | 487,929,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 15,691,000Source | 15,328,000Source | 13,222,000Source | 12,584,000Source |
| Operating Lease, Liability, CurrentUSD | 2,575,000Source | 2,312,000Source | 2,295,000Source | 1,842,000Source |
| Operating Lease, Liability, NoncurrentUSD | 21,077,000Source | 23,652,000Source | 25,964,000Source | 28,032,000Source |
| Other Liabilities, NoncurrentUSD | 8,000Source | 48,000Source | 179,000Source | 320,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 7,135,000Source | 7,937,000Source | 9,212,000Source | 8,298,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 240,600,000Source | 299,500,000Source | 373,100,000Source | 426,400,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 0Source | 0Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -92,966,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 15,414,000Source | 28,207,000Source | 34,424,000Source | 33,673,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -277,000Source | -487,000Source | -302,000Source | 1,820,000Source |
| Increase (Decrease) in InventoriesUSD | 2,901,000Source | 2,668,000Source | 1,948,000Source | 1,590,000Source |
| Increase (Decrease) in Accounts PayableUSD | 1,062,000Source | 3,355,000Source | -987,000Source | -1,553,000Source |
| Deferred Income Tax Expense (Benefit)USD | -6,000Source | -248,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -44,448,000Source | -46,109,000Source | -59,065,000Source | -60,780,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 61,548,000Source | 65,858,000Source | 37,904,000Source | -122,718,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,797,000Source | 3,584,000Source | 7,309,000Source | 10,265,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | 0Source | 13,000Source | 20,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -10,568,000Source | -11,495,000Source | 452,000Source | 3,893,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 6,532,000Source | 8,254,000Source | -20,709,000Source | -179,605,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 47,809,000Source | 41,277,000Source | 33,023,000Source | 53,732,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 182,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 15,414,000Source | 28,207,000Source | 34,424,000Source | 33,673,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 240,600,000Source | 299,500,000Source | 373,100,000Source | 426,400,000Source |
| DepreciationUSD | 6,100,000Source | 6,200,000Source | 5,600,000Source | 3,900,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -1,014,000Source | -279,000Source | -399,000Source | -332,000Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | 0Source | 0Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | -5,919,000Source | -2,649,000Source | — | — |
| Income Tax Expense (Benefit)USD | 201,000Source | 98,000Source | 0Source | 0Source |
| Inventory Write-downUSD | 148,000Source | 179,000Source | 872,000Source | 507,000Source |
| Investment Income, InterestUSD | 11,522,000Source | 16,666,000Source | 17,764,000Source | 4,602,000Source |
| Net Income (Loss) Attributable to ParentUSD | -73,600,000Source | -86,599,000Source | -86,277,000Source | -92,966,000Source |
| Nonoperating Income (Expense)USD | 4,593,000Source | 13,600,000Source | 17,186,000Source | 4,269,000Source |
| Operating ExpensesUSD | 86,457,000Source | 107,156,000Source | 111,969,000Source | 104,328,000Source |
| Operating Lease, ExpenseUSD | -9,000Source | 91,000Source | 211,000Source | 1,959,000Source |
| Operating Lease, Lease IncomeUSD | — | — | 100,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 237,814,000Source | 342,025,000Source | 445,315,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 56,000Source | 0Source | 97,000Source | 3,138,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 16,578,000Source | 14,170,000Source | 16,661,000Source | 15,493,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 42,583,000Source | 56,571,000Source | 58,950,000Source | 58,531,000Source |
| Operating Income (Loss)USD | -77,992,000Source | -100,101,000Source | -103,463,000Source | -97,235,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -73,399,000Source | -86,501,000Source | — | — |
| Income Tax Expense (Benefit)USD | 201,000Source | 98,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -73,600,000Source | -86,599,000Source | -86,277,000Source | -92,966,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.35Source | -1.49Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.35Source | -1.49Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 63,850,490Source | 62,433,613Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 63,850,490Source | 62,433,613Source |
| Additional Financial Items | ||||
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0Source | 0Source | 0Source | — |
| Current Income Tax Expense (Benefit)USD | 207,000Source | 346,000Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 5,123,000Source | 5,836,000Source | — | — |
| Gross ProfitUSD | 8,465,000Source | 7,055,000Source | 8,506,000Source | 7,093,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -5,919,000Source | -2,649,000Source | — | — |
| Interest ExpenseUSD | — | — | — | 0Source |
| Investment Income, InterestUSD | 11,522,000Source | 16,666,000Source | 17,764,000Source | 4,602,000Source |
| Labor and Related ExpenseUSD | 35,042,000Source | 36,774,000Source | — | — |
| Nonoperating Income (Expense)USD | 4,593,000Source | 13,600,000Source | 17,186,000Source | 4,269,000Source |
| Operating ExpensesUSD | 86,457,000Source | 107,156,000Source | 111,969,000Source | 104,328,000Source |
| Operating Lease, ExpenseUSD | -9,000Source | 91,000Source | 211,000Source | 1,959,000Source |
| Operating Lease, Lease IncomeUSD | — | — | 100,000Source | — |
| Other General ExpenseUSD | 2,902,000Source | 5,076,000Source | — | — |
| Research and Development ExpenseUSD | 43,874,000Source | 50,585,000Source | 53,019,000Source | 45,797,000Source |
Filing attachments
ck0001726445-ex99_1.htm · 8-K · 2026-08-11
EX-99.1 2 ck0001726445-ex99_1.htm EX-99.1 EX-99.1 Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook REDWOOD CITY, Calif. - August 11, 2026 - Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended June 30, 2026. Recent Highlights • Achieved revenue of $3.1 million in the second quarter of 2026 • Our collaborators from Korea Un…
Read attachment ↗ck0001726445-ex99_1.htm · 8-K · 2026-07-31
EX-99.1 2 ck0001726445-ex99_1.htm EX-99.1 EX-99.1 Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. No Stockholder Action Required at This Time REDWOOD CITY, Calif. - July 2, 2026 - Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding s…
Read attachment ↗ck0001726445-ex99_2.htm · 8-K · 2026-07-31
EX-99.2 3 ck0001726445-ex99_2.htm EX-99.2 EX-99.2 Omid Farokhzad, M.D. Chief Executive Officer Seer, Inc. 3800 Bridge Parkway, Redwood City, CA 94065 July 1, 2026 CONFIDENTIAL - DELIVERED PERSONALLY The Board of Directors Seer, Inc. 3800 Bridge Parkway, Redwood City, CA 94065 Attention: Lead Independent Director and Members of the Board of Directors Re: Proposal to Take Seer, Inc. Private at $2.45 per Share in Cash Plus Two Contingent Value Rights Dear Members of the Board: After care…
Read attachment ↗ck0001726445-ex99_1.htm · 8-K · 2026-07-31
EX-99.1 2 ck0001726445-ex99_1.htm EX-99.1 EX-99.1 Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. No Stockholder Action Required at This Time REDWOOD CITY, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that on July 28, 2026, it received a further revised, unsolicited, non-binding acquisition proposal fr…
Read attachment ↗ck0001726445-ex99_2.htm · 8-K · 2026-07-31
EX-99.2 3 ck0001726445-ex99_2.htm EX-99.2 EX-99.2 Omid Farokhzad, M.D. Chief Executive Officer Seer, Inc. 3800 Bridge Parkway Redwood City, CA 94065 July 29, 2026 CONFIDENTIAL - DELIVERED PERSONALLY The Special Committee of the Board of Directors Seer, Inc. 3800 Bridge Parkway Redwood City, CA 94065 Attention: Members of the Special Committee Re: Revised Proposal to Take Seer, Inc. Private Dear Members of the Special Committee: After careful reflection, I am writing in my personal cap…
Read attachment ↗d105079dex991.htm · 8-K · 2026-07-20
EX-99.1 2 d105079dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. REDWOOD CITY, Calif., July 20, 2026 (GLOBE NEWSWIRE) - Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors, consisting of independent directors Meeta Gulyani and Nicolas Roelofs, Ph. D., has t…
Read attachment ↗